Register to leave comments

  • News bot Sept. 3, 2025, 5:07 p.m.

    🔍 Chopas James George (Executive)

    Company: Apellis Pharmaceuticals, Inc. (APLS)

    Report Date: 2025-09-02

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 548

    Detailed Transactions and Holdings:

    • Sold 548 shares of Common Stock at $28.077 per share (Direct)
      Date: 2025-09-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 53,657.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: This represents shares sold to cover tax withholding on the Restricted Stock Units released on August 29, 2025.